The exact role of different types of dietary fat and the best approach to prevention in cardiovascular disease has been ...

There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides ...

Nonprescription rosuvastatin pans out in a second trialThe TACTiC study included 1,196 participants (median age 63, 39.6% women) who completed the web app assessment and got the OK to use statins ...

METHODOLOGY: Previous studies have shown the efficacy of inclisiran in lowering the level of LDL cholesterol when used in combination with statins in patients with a high risk for atherosclerosis ...

Interim data from the REPRIEVE study showed that a daily statin cut the risk for cardiovascular events by 35% in adults with HIV at low to moderate CV risk.

The outcomes of interest were the drug's acceptability, tolerability, and efficacy. The researchers measured acceptability as the ratio of discontinuations (due to any cause) from initiation of ...

Among the 3,157 patients aged 80 years and older, compared with those who had a statin prescription of less than 2 years or none at all, those who had a statin prescription for 2 years had lower ...

Concomitant use of statins improved survival among people with cancer treated with immune checkpoint inhibitors, according to results of a meta-analysis. “These findings highlight the potential ...

In several studies, bempedoic acid reduced the level of LDL cholesterol by 17 to 28%, a finding that, in 2020, prompted its approval by the Food and Drug Administration and the European Medicines ...

Based on robust randomized trial data and meta-analyses, FAU experts conclude that statins – particularly rosuvastatin and ...